Literature DB >> 10908972

Electronystagmographic findings in patients with acute cerebral vascular disease and vertigo.

P Silvoniemi1, E Laurikainen, R Johansson, S Karjalainen.   

Abstract

A neurootologist examined 233 successive cases of acute disabling vertigo from the Clinic of Neurology of Turku University Central Hospital. On magnetic resonance imaging (MRI), 24 patients had evidence of acute cerebral or cerebellar brain infarction. The examination scheme included a case history analysis, clinical neurootological examination and electronystagmography (ENG). The audiological examination included pure-tone thresholds and speech audiometry. The ENG analyses were done by two neurootologists who had no information about the aetiology of the diseases. A central disturbance in ENG was observed in 59% (10/17) of the patients with cerebral brain infarction and 71% (5/7) of the patients with cerebellar brain infarction. ENG is not valid as a screening method for the central aetiology of vertigo; imaging of the central nervous system is needed.

Entities:  

Mesh:

Year:  2000        PMID: 10908972     DOI: 10.1080/000164800453919-1

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  3 in total

1.  Saccades and smooth pursuit eye movements in central vertigo.

Authors:  G Tirelli; S Rigo; F Bullo; C Meneguzzi; D Gregori; A Gatto
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-04       Impact factor: 2.124

2.  Applicability of Oculomotor Tests for Predicting Central Vestibular Disorder Using Principal Component Analysis.

Authors:  Ching-Nung Wu; Sheng-Dean Luo; Shu-Fang Chen; Chi-Wei Huang; Pi-Ling Chiang; Chung-Feng Hwang; Chao-Hui Yang; Chun-Hsien Ho; Wei-De Cheng; Chung-Ying Lin; Yi-Lu Li
Journal:  J Pers Med       Date:  2022-02-02

3.  Vestibular function in carotid territory stroke patients.

Authors:  Anna Paula Batista de Ávila Pires; Marcia Maiumi Fukujima; Fernando Freitas Ganança; Letícia de Moraes Aquino; Maurício Malavasi Ganança; Heloisa Helena Caovilla
Journal:  Braz J Otorhinolaryngol       Date:  2013 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.